Onycho Pharma has acquired rights for Amycot® in the USA and will conduct a clinical trial program to permit out-license of product for commercialisation as a prescription medicine. Amycot® is a highly efficacious natural treatment to manage onychomycosis using a patented bioactive extract from the...See more
Headquarters:
Singapore
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2019 (6 years)
Address:
190 CLEMENCEAU AVENUE #06-01; SINGAPORE, STATE/PROVINCE 239924, SG
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
HIGH
spending power
